Lu Pei
Impact in
-
- Hepatitis C virus research
-
- Cancer-related molecular mechanisms research
Papers in
-
- Glycosylation and Glycoproteins Research 1
-
- Immunotherapy and Immune Responses 2
- Immune Response and Inflammation 2
- Co-authors
- Liping Dai (5 shared papers)Jianying Zhang (5 shared papers)Hua Ye (4 shared papers)Kaijuan Wang (4 shared papers)Hongchun Liu (3 shared papers)Tingting Wang (4 shared papers)Peng Wang (3 shared papers)Man Liu (3 shared papers)
In The Last Decade
Lu Pei
17 papers receiving 234 citations
Peers
Comparison fields: 5 of 51
- Hepatology 23
- Cancer Research 30
- Oncology 49
- Radiology, Nuclear Medicine and Imaging 37
- Immunology 34
Countries citing papers authored by Lu Pei
This map shows the geographic impact of Lu Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Pei more than expected).
Fields of papers citing papers by Lu Pei
This network shows the impact of papers produced by Lu Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Pei. The network helps show where Lu Pei may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Pei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 34 | |
| 2 | 2019 | 30 | |
| 3 | 2017 | 25 | |
| 4 | 2019 | 23 | |
| 5 | 2019 | 23 | |
| 6 | 2017 | 22 | |
| 7 | 2021 | 20 | |
| 8 | 2023 | 15 | |
| 9 | 2022 | 14 | |
| 10 | [Prophylactic effect of amifostine on oxaliplatin-related neurotoxicity in patients with digestive tract tumors]. | 2008 | 12 |
| 11 | 2017 | 6 | |
| 12 | 2024 | 5 | |
| 13 | 2014 | 4 | |
| 14 | 2025 | 2 | |
| 15 | 2023 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2024 | 0 | |
| 20 | 2025 | 0 |
About Lu Pei
Lu Pei is a scholar working on Molecular Biology, Immunology, Oncology, Radiology, Nuclear Medicine and Imaging and Periodontics, having authored 20 papers that have together received 238 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer Treatment and Pharmacology (2 papers), Oral microbiology and periodontitis research (2 papers), Immunotherapy and Immune Responses (2 papers), Immune Response and Inflammation (2 papers), Glycosylation and Glycoproteins Research (1 paper), Cancer Genomics and Diagnostics (1 paper) and Wound Healing and Treatments (1 paper). The work is most often cited by research in Hepatology (23 citations), Cancer Research (30 citations), Oncology (49 citations), Radiology, Nuclear Medicine and Imaging (37 citations) and Immunology (34 citations). Lu Pei has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Liping Dai, Jianying Zhang, Hua Ye, Kaijuan Wang, Hongchun Liu, Tingting Wang, Peng Wang, Man Liu, Songyun Ouyang and Yongxu Jia. Their work appears in journals such as Immunobiology, Frontiers in Immunology, Advanced Science, The FASEB Journal and npj Biofilms and Microbiomes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.